nodes	percent_of_prediction	percent_of_DWPC	metapath
Anisotropine Methylbromide—CHRM1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0208	0.0208	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0207	0.0207	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0205	0.0205	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Other—P2RY11—narcolepsy	0.0194	0.0194	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Other—P2RY11—narcolepsy	0.0192	0.0192	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Monoamine GPCRs—HTR2A—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Monoamine GPCRs—HTR2A—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Monoamine GPCRs—HTR2A—narcolepsy	0.0122	0.0122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—P2RY11—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—HCRTR2—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—HCRTR1—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00976	0.00976	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00973	0.00973	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—HCRT—narcolepsy	0.00928	0.00928	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—HCRT—narcolepsy	0.00925	0.00925	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00873	0.00873	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00873	0.00873	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0087	0.0087	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0087	0.0087	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00862	0.00862	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00862	0.00862	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00843	0.00843	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00841	0.00841	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00833	0.00833	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0083	0.0083	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00827	0.00827	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00748	0.00748	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00748	0.00748	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00746	0.00746	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00746	0.00746	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00739	0.00739	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00739	0.00739	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00723	0.00723	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0072	0.0072	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00713	0.00713	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00703	0.00703	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.00701	0.00701	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.0068	0.0068	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00629	0.00629	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00627	0.00627	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00614	0.00614	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00612	0.00612	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00606	0.00606	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00583	0.00583	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.0057	0.0057	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.0057	0.0057	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00568	0.00568	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00568	0.00568	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00562	0.00562	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00562	0.00562	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.0055	0.0055	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00548	0.00548	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00548	0.00548	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00546	0.00546	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00545	0.00545	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00543	0.00543	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00541	0.00541	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.0054	0.0054	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00511	0.00511	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00511	0.00511	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00509	0.00509	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00509	0.00509	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00507	0.00507	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00482	0.00482	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00477	0.00477	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00475	0.00475	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0047	0.0047	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00468	0.00468	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00466	0.00466	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00466	0.00466	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00464	0.00464	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00462	0.00462	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00457	0.00457	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00457	0.00457	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00417	0.00417	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00408	0.00408	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00407	0.00407	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00403	0.00403	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00355	0.00355	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00353	0.00353	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.0035	0.0035	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00338	0.00338	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00338	0.00338	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00337	0.00337	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00337	0.00337	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00334	0.00334	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00334	0.00334	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00322	0.00322	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00322	0.00322	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00321	0.00321	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00321	0.00321	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00306	0.00306	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.0024	0.0024	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CHKB—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00213	0.00213	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00211	0.00211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00203	0.00203	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.002	0.002	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.002	0.002	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CPT1B—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.00145	0.00145	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.00145	0.00145	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PENK—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PENK—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PENK—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TRH—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TRH—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000943	0.000943	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.00094	0.00094	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.00093	0.00093	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000876	0.000876	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000873	0.000873	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000865	0.000865	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000795	0.000795	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000793	0.000793	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000785	0.000785	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000781	0.000781	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000781	0.000781	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000779	0.000779	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000779	0.000779	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000771	0.000771	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000771	0.000771	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.00047	0.00047	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000468	0.000468	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000464	0.000464	CbGpPWpGaD
